期刊文献+

同型半胱氨酸水平对稳定型心绞痛患者介入治疗后血小板抑制率的影响 被引量:4

Analysis of platelet inhibition in stable angina pectoris patients complicated with hyperhomocystinemia after PCI
下载PDF
导出
摘要 目的分析同型半胱氨酸水平对稳定型心绞痛患者介入治疗后血栓弹力图检测结果的影响。方法随机抽取北京安贞医院和阜外医院201 1年1月—2013年12月行冠脉介入治疗的患者450例,按照是否合并高同型半胱氨酸血症分为高同型半胱氨酸血症组(n=138)和正常同型半胱氨酸组(n=312),2组患者经常规术前检查、药物治疗和冠状动脉支架置入,入院后行常规检查及血栓弹力图检测。分析血栓弹力图各指标在2组间的差异。结果高同型半胱氨酸血症组男性占比、年龄、体质量、吸烟、高血压、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、左室射血分数、高敏C反应蛋白显著高于正常同型半胱氨酸组(P<0.05),多因素回归分析显示,在控制上述组间有统计学差异的各因素之后,高同型半胱氨酸血症与二磷酸腺苷抑制率仍显著相关(r=0.889,P=0.000)。2组患者的血栓弹力图主要参数,包括R值、K值、α角和血栓形成的最大幅度(MA)差异均有统计学意义(P<0.05);2组花生四烯酸(AA)抑制率差异无统计学意义(P=0.072),而二磷酸腺苷(ADP)抑制率差异有显著统计学差异(P=0.000);且高同型半胱氨酸血症组氯吡格雷抵抗的发生率显著高于正常同型半胱氨酸组(26.8%vs.16.1%,P=0.022)。结论合并高同型半胱氨酸血症的稳定型心绞痛患者呈现高凝状态,且氯吡格雷抵抗发生率高,提示冠状动脉介入术后需要加强抗血小板治疗以减少心血管事件。 Objective To analysis the effect of homocysteine levels on the detection of the patients with stable angina pectoris after PCI .Methods Randomly selected Beijing Anzhen Hospital and Fuwai Hospital from 2011 January to 2013 De-cember 450 coronary interventional patients , according to whether with high homocysteine hyperlipidemia or not , patients were divided into high homocysteine hyperlipidemia group ( n =138) and normal cysteine groups ( n =312), 2 groups of patients underwent the preoperative examination , drug therapy and coronary artery stent implantation , after admission , they underwent routine examination and thrombosis elastic graph detection .Analysis the index of the blood clots ’ differences between the 2 groups.Results High homocysteine group’s male patients ’ ratio, age, body weight, smoking, hypertension, low density lip-oprotein cholesterol , high density fat cholesterol ,left ventricular ejection fraction , hypersensitive C-reactive protein were sig-nificantly higher than that of normal homocysteine cysteine groups ( P &lt;0.05).Multivariate regression analysis showed that , after control the various factors , statistically significant difference between and hyperhomocysteinemia and diphosphate adeno -sine inhibition rate were still existed (r =0.889, P =0.000).Two groups of patients’ thromboelastography’s main parame -ters, including the R value, value K, alpha angle, and thrombosis of the maximum amplitude (MA) showed significant differ-ences ( P &lt;0.05); arachidonic acid (AA ) inhibition rate’s difference was not statistically significant ( P =0.072) and adenosine diphosphate( ADP) inhibition rate in the two groups had significant statistical differences ( P =0.000);and high&amp;nbsp;homocysteine clopidogrel resistance was significantly higher than that of the normal homocysteine cysteine groups (26 a.8%vs. 16.1%, P =0.022).Conclusion Patients with stable angina pectoris with high homocysteine showed a high level of coagu -lation, and the incidence of clopidogrel resistance was high , suggesting that the need to strengthen anti platelet therapy after coronary intervention to reduce cardiovascular events .
出处 《疑难病杂志》 CAS 2015年第10期991-995,共5页 Chinese Journal of Difficult and Complicated Cases
基金 国家自然科学基金(No.81000130 81000091) 首都临床特色应用研究项目(No.Z13110700220000)
关键词 稳定性心绞痛 经皮冠状动脉介入 高同型半胱氨酸血症 血栓弹力图 花生四烯酸抑制率 二磷酸腺苷抑制率 Stable angina pectoris Percutaneous coronary intervention Hyperhomocystinemia Thromboelastography Arachidonic acid inhibition rate Adenosine diphosphate inhibition rate
  • 相关文献

参考文献22

  • 1Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention : a report of the Ameri- can college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiogra- phy and intervemions [ J ]. Circulation, 2011,124 ( 23 ) : e574 -e651.
  • 2Hobson AR, Agarwala RA, Swallow RA, et al. Thrombelastography: current clinical applications and its potential role in interventional cardi- ology[ J3. Platelets ,2006,17 ( 8 ) :509-518.
  • 3肖文琦,吴永健.血栓弹力图法与比浊法在冠心病患者血小板功能检测中的比较[J].中国循环杂志,2013,28(4):318-320. 被引量:35
  • 4Montalescot G, Ankri A, Chadefauxvekemans B, et al. Plasma homocys- teine and the extent of atherosclerosis in patients with coronary artery disease [ J ]. Int J Cardiol, 1997,60 ( 3 ) :295-300.
  • 5无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2045
  • 6Malinow MR, Bostom AG, Krauss RM. Homocysteine, diet , and cardi- ovascular disease : A statement f or heahhcare professionals from the Nu trition commit tee, American Heart Association [ AHA Science Advisory [ J ]. Circulation, 1999,99 ( 1 ) : 178-182 .
  • 7惠汝太.炎症反应与动脉粥样硬化及急性冠状动脉综合征[J].中国循环杂志,2000,15(5):259-260. 被引量:50
  • 8Guba SC, Fink LM, Hyperhomocysteinemia FV. An emerging and impor- tant risk factor for thromembolic and cardiovascular disease [ J ]. Am J Clin Pathol, 1996,106 (6) :709-722.
  • 9Benser J, Valtuena J, Ruiz JR, et al. Impact of physical activity and car- diovascular fitness on total homocysteine concentrations in European ad- olescents : the Helena study[ J ]. J Nutr Sci Vitaminol ( Tokyo), 2015, 61(1) :45-54.
  • 10Must A, Jacques PF, Rogers G, et al. Serum total homoeysteine concen- trations in children and adolescents: results from the third National Health and Nutrition Examination Survey ( NHANES III) [ J ]. J Nutr, 2003,133 (8) :2643-2649.

二级参考文献132

共引文献2203

同被引文献48

  • 1王桂红,王拥军,姜卫剑,杜彬,金旻.吸烟与青年脑大动脉粥样硬化性狭窄的相关性分析[J].中国卒中杂志,2006,1(2):88-90. 被引量:12
  • 2王嗣欣,周丽红,赵亮,林大正,高燕军,米艳娟,刘志华,陈启东.颅内外血管狭窄支架术前后血浆同型半胱氨酸的变化及与再狭窄的关系[J].天津医药,2007,35(1):21-23. 被引量:2
  • 3饶明利,王文志,黄如训,等.中国脑血管病防治指南[M].北京:人民卫生出版社.2007:4.
  • 4Wald DS,Wald NJ,Morris JK, et al. Folic acid, homocys- teine, and cardiovascular disease :judging causality in the face of inconclusive trial evidence [J]. BMJ,2006,333 (757):1114-1117.
  • 5Jaffre A,Ruidavets JB,Calviere L,et al. Risk factor profile by etiological subtype of ischemic stroke in the young [J]. Clinical Neurology and Neurosurgery, 2014; 120: 78-83.
  • 6O'Donnell MJ,Xavier D,Liu L,et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study) : a case-control study [J]. Lancet, 2010,376(9735) : 112-123.
  • 7Gibson CL Cerebralis'chemic stroke:is genderimportant? [J]. J Cereb Blood Flow Metab,2013,33(9) : 1355-1361.
  • 8Graham IM,Daly LE,Refsum HM,et al. Plasma homo- cysteine as a risk factor for vascular disease. The Euro- pean Concerted Action Project [J]. JAMA, 1997,277(1997) : 1775-1781.
  • 9Wang X,Qin X,Demirtas H,et al. Efficacy of folio acid sup- plementation in stroke prevention:a meta-analysis [J]. Lancet, 2007,369 (9576) : 1876-1882.
  • 10Lee M,Hong KS, Chang SC, et al. Efficacy of homocys- teine-lowering therapy with folio Acid in stroke preven- tion:a recta-analysis [J]. Stroke,2010,41(6) : 1205-1212.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部